+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Preclinical Imaging Market - Growth, Trends, and Forecast (2019 - 2024)

  • ID: 4591717
  • Report
  • May 2019
  • Region: Global
  • 112 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aspect Imaging Ltd
  • Bruker Corporation
  • Li-Cor Biosciences
  • Mediso Ltd
  • Milabs BV
  • MR Solutions Ltd
  • MORE
Market Overview

The major factors for the growth of the preclinical imaging market include the technological advancements in molecular imaging, increasing demand for non-invasive small animal imaging techniques, and increase in preclinical research funding, by both private and public organizations.

Molecular imaging is a rapidly developing multidiscipline, which involves molecular biology, chemistry, computer, engineering, and medicine. It can recognize noninvasive and real-time visualization, measurement of the physiological or pathological process in the living organism at the cellular or molecular level. Multimodal molecular imaging can play important role in the clinical care of various diseases by improving clinicians’ ability to perform screening, surveillance, staging, prognosis, planning and therapy guidance, monitoring therapy efficacy, and assessing recurrence. With its rapid technological advances, presymptomatic detection, targeted therapy, and personalized medicine may be possible in the near future through the use of multimodal molecular imaging. Aspect imaging developed Aspect’s M2 platform and suite of products enables researchers to harness the power and quantitative insights of MRI for small animal phenotyping and drug development but without the cost, complexity, and technical burden of traditional MRI systems. In 2018, next-generation SPECT cameras with cadmium zinc telluride (CZT) detectors can lower patient radiation dose and shorten examination time. Thus, introduction of innovative products is likely to augment the growth of the preclinical imaging market.

Scope of the Report

As per the scope of this report, preclinical imaging is the visualization technique of living animals for research purposes. The market is segmented by modality and geography.

Key Market Trends

Micro-Ultrasound is the Segment by Modality and is expected to be the Fastest Growing Market

Micro-ultrasound is a miniature version of ultrasound that has a wider range of applications, especially in research related to the small animal models. These smaller versions of imaging techniques boost the efficacy of the techniques. Also, they reduce the number of animals required for a particular study. Over the past decade, preclinical imaging has emerged as an important tool to facilitate biomedical discovery. The high-frequency micro-ultrasound steadily evolved in the post-genomic era as a rapid, comparatively inexpensive imaging tool for studying normal development and models of human disease in small animals. One of the fundamental barriers to this development was the technological hurdle associated with high-frequency array transducers. The applications of preclinical micro-ultrasound are explored for developmental biology, cancer, and cardiovascular disease. With respect to the future, the latest developments in high-frequency ultrasound imaging are also being developed. The combination of multiple imaging modalities in preclinical studies will help the researchers to understand the molecular, cellular, and physiological changes in living animals and to predict the outcome of new treatments in patients. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

North America is Expected to Dominate the Market

North America is expected to dominate the preclinical imaging market, due to the fact that the region has the maximum number of skilled professionals, developed infrastructure, a large number of preclinical projects, and higher adoption rates of technically advanced devices in the region. The United States is also found to be dominating the market, owing to the presence of established infrastructure and the presence of major public and private companies. The preclinical imaging is found increasingly used in the target identification, compound optimization, and in the drug development process. There has been an increased research and development funding that is taking place, coupled with the presence of a highly developed research infrastructure, which is accelerating the growth of the preclinical imaging market in the United States. In September 2017, Aspect Imaging, one of the market player in design and development of compact magnetic resonance systems for preclinical, medical, and industrial applications, has announced that Quantum analytics would be its exclusive US Distributor for Aspect Imaging’s Industrial product portfolio. Thus, all these factors have contributed to the growth of the market.

Competitive Landscape

The market studied is a moderately consolidated market owing to the various small and large market players. Some of the market players are Aspect Imaging Ltd, Bruker Corporation, Fujifilm Holdings Corporation, Li-Cor Biosciences, Mediso Ltd, Milabs BV, MR Solutions Ltd, PerkinElmer Inc., and Trifoil Imaging.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aspect Imaging Ltd
  • Bruker Corporation
  • Li-Cor Biosciences
  • Mediso Ltd
  • Milabs BV
  • MR Solutions Ltd
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Molecular Imaging
4.2.2 Increasing Demand for Non-invasive Small Animal Imaging Techniques
4.2.3 Increase in Preclinical Research Funding, by Both Private and Public Organizations
4.3 Market Restraints
4.3.1 Strict Regulations in Preclinical Research
4.3.2 High Installation and Operational Costs associated with Preclinical Imaging Modalities
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Modality
5.1.1 Optical Imaging Systems
5.1.2 Nuclear Imaging Systems
5.1.3 Micro-MRI
5.1.4 Micro-Ultrasound
5.1.5 Micro-CT
5.1.6 Photoacoustic Imaging Systems
5.1.7 Others
5.2 Geography
5.2.1 North America
5.2.1.1 US
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 UK
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South Africa

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aspect Imaging Ltd
6.1.2 Bruker Corporation
6.1.3 Fujifilm Holdings Corporation
6.1.4 Li-Cor Biosciences
6.1.5 Mediso Ltd
6.1.6 Milabs BV
6.1.7 MR Solutions Ltd
6.1.8 PerkinElmer Inc.
6.1.9 Trifoil Imaging

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aspect Imaging Ltd
  • Bruker Corporation
  • Fujifilm Holdings Corporation
  • Li-Cor Biosciences
  • Mediso Ltd
  • Milabs BV
  • MR Solutions Ltd
  • PerkinElmer Inc.
  • Trifoil Imaging
Note: Product cover images may vary from those shown
Adroll
adroll